Eli Lilly Gains 4% on Better Than Expected Q3 Results
November 2, 2023 Cbonds
Show full article |
This functionality is available for registred users only
|
Issuer — Eli Lilly
-
Full nameEli Lilly & Company
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
Share